151636-13-4
Chemical Structure
C18:0 GD3 Ceramide (d18:1/18:0), synthetic
- CAS No.: 151636-13-4
- Formula:C70H125N3O29
- Molecular Weight:1472.74
InChIKey: CSXAHYACQIWDLT-RBJKPCLLSA-N
SMILES: OC[C@@H](O)[C@@H](O)[C@H]1[C@@H](NC(C)=O)[C@@H](O)C[C@@](C(O)=O)(O[C@@H]([C@H]([C@H]2C(NC(C)=O)[C@@H](O)C[C@@](C(O)=O)(O[C@H]3[C@@H](O)[C@H](O[C@H]4[C@@H](O)[C@H]([C@H](OC[C@H](NC(CCCCCCCCCCCCCCCCC)=O)C(O)/C=C/CCCCCCCCCCCCC)O[C@@H]4CO)O)O[C@H](CO)[C@@H]3O)O2)O)CO)O1
Biological Activity: C18:0 GD3 Ceramide (d18:1/18:0), synthetic is a synthetic ganglioside. C18:0 GD3 Ceramide (d18:1/18:0), synthetic is a derivative of GD3 Ganglioside (HY-157343). C18:0 GD3 Ceramide (d18:1/18:0), synthetic can be used for research on melanoma and glioblastoma multiforme[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
C18:0 GD3 Ceramide (d18:1/18:0), synthetic | C18:0 GD3 Ceramide (d18:1/18:0), synthetic is a synthetic ganglioside. C18:0 GD3 Ceramide (d18:1/18:0), synthetic is a derivative of GD3 Ganglioside (HY-157343). C18:0 GD3 Ceramide (d18:1/18:0), synthetic can be used for research on melanoma and glioblastoma multiforme. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
C18:0-d7 GD3 Ceramide (d18:1/18:0-d7) | C18:0-d7 GD3 Ceramide (d18:1/18:0-d7) is deuterium labeled C18:0 GD3 Ceramide (d18:1/18:0). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Malisan F, et al. GD3 ganglioside and apoptosis. Biochimica et biophysica acta. 2002 Dec 30;1585(2-3):179-87. [Content Brief]
- [2]. Posse de Chaves E, et al. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS letters. 2010 May 03;584(9):1748-59.
- [3]. Fabris D, et al. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization. Biochimie. 2017 Jun;137:56-68.
- [4]. Sarbu M, et al. Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry. International journal of molecular sciences. 2022 Jan 08;23(2):693. [Content Brief]
